
Dameron Levest Jones
Examiner (ID: 18762, Phone: (571)272-0617 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1621, 1616, 3991, 1211, 1618, RD00, 1619, 1622, 1615 |
| Total Applications | 2574 |
| Issued Applications | 1523 |
| Pending Applications | 392 |
| Abandoned Applications | 685 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10755046
[patent_doc_number] => 20160101198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'METHOD OF DIAGNOSING AND TREATING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/891835
[patent_app_country] => US
[patent_app_date] => 2014-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2088
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/891835 | Method of diagnosing and treating Alzheimer's disease | May 20, 2014 | Issued |
Array
(
[id] => 11581784
[patent_doc_number] => 09636404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging'
[patent_app_type] => utility
[patent_app_number] => 14/275885
[patent_app_country] => US
[patent_app_date] => 2014-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 32
[patent_no_of_words] => 10282
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14275885
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/275885 | Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging | May 12, 2014 | Issued |
Array
(
[id] => 9805236
[patent_doc_number] => 20150017180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'TREATMENT OF CHRONIC INFLAMMATORY CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/275605
[patent_app_country] => US
[patent_app_date] => 2014-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6995
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14275605
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/275605 | TREATMENT OF CHRONIC INFLAMMATORY CONDITIONS | May 11, 2014 | Abandoned |
Array
(
[id] => 10974142
[patent_doc_number] => 20140377177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules'
[patent_app_type] => utility
[patent_app_number] => 14/273163
[patent_app_country] => US
[patent_app_date] => 2014-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 57608
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14273163
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/273163 | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules | May 7, 2014 | Issued |
Array
(
[id] => 9685229
[patent_doc_number] => 20140241993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'FLUORESCENT CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/273374
[patent_app_country] => US
[patent_app_date] => 2014-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 9391
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14273374
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/273374 | FLUORESCENT CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER | May 7, 2014 | Abandoned |
Array
(
[id] => 13645805
[patent_doc_number] => 09849201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Homing agents
[patent_app_type] => utility
[patent_app_number] => 14/270061
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 100
[patent_figures_cnt] => 97
[patent_no_of_words] => 22231
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270061
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/270061 | Homing agents | May 4, 2014 | Issued |
Array
(
[id] => 10905192
[patent_doc_number] => 20140308205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'TRIFUNCTIONAL AND COMPLETELY CLEARABLE SPECIFIC TARGETING AGENTS AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/250632
[patent_app_country] => US
[patent_app_date] => 2014-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9695
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14250632
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/250632 | TRIFUNCTIONAL AND COMPLETELY CLEARABLE SPECIFIC TARGETING AGENTS AND METHODS THEREOF | Apr 10, 2014 | Abandoned |
Array
(
[id] => 9642502
[patent_doc_number] => 20140220612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION'
[patent_app_type] => utility
[patent_app_number] => 14/247619
[patent_app_country] => US
[patent_app_date] => 2014-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29921
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14247619
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/247619 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Apr 7, 2014 | Abandoned |
Array
(
[id] => 10098021
[patent_doc_number] => 09134328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Methods of using benzothiazole derivative compounds and compositions'
[patent_app_type] => utility
[patent_app_number] => 14/246890
[patent_app_country] => US
[patent_app_date] => 2014-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9804
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14246890
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/246890 | Methods of using benzothiazole derivative compounds and compositions | Apr 6, 2014 | Issued |
Array
(
[id] => 11522729
[patent_doc_number] => 09606123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Compositions and methods for diagnosing and monitoring ovarian cancer progression and treatment'
[patent_app_type] => utility
[patent_app_number] => 14/228828
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 28426
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14228828
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/228828 | Compositions and methods for diagnosing and monitoring ovarian cancer progression and treatment | Mar 27, 2014 | Issued |
Array
(
[id] => 12193881
[patent_doc_number] => 09897604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => '4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/215930
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15548
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14215930
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/215930 | 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof | Mar 16, 2014 | Issued |
Array
(
[id] => 9735743
[patent_doc_number] => 20140271456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'RADIOTRACER IMAGING USING SODIUM IODIDE SYMPORTER POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/209369
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7889
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209369
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/209369 | RADIOTRACER IMAGING USING SODIUM IODIDE SYMPORTER POLYPEPTIDES | Mar 12, 2014 | Abandoned |
Array
(
[id] => 9735767
[patent_doc_number] => 20140271479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA'
[patent_app_type] => utility
[patent_app_number] => 14/209004
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 27739
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209004
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/209004 | Optogenetic control of inputs to the ventral tegmental area | Mar 12, 2014 | Issued |
Array
(
[id] => 10684458
[patent_doc_number] => 20160030603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'DETECTION OF ACUTE RENAL ALLOGRAFT REJECTION'
[patent_app_type] => utility
[patent_app_number] => 14/776720
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29659
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776720
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776720 | DETECTION OF ACUTE RENAL ALLOGRAFT REJECTION | Mar 12, 2014 | Abandoned |
Array
(
[id] => 9735752
[patent_doc_number] => 20140271465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'MATRIX METALLOPROTEASE (MMP) TARGETED AGENTS FOR IMAGING AND THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/208350
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12717
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14208350
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/208350 | MATRIX METALLOPROTEASE (MMP) TARGETED AGENTS FOR IMAGING AND THERAPY | Mar 12, 2014 | Abandoned |
Array
(
[id] => 9735756
[patent_doc_number] => 20140271468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'ASTHMA IMAGING'
[patent_app_type] => utility
[patent_app_number] => 14/206904
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15177
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14206904
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/206904 | ASTHMA IMAGING | Mar 11, 2014 | Abandoned |
Array
(
[id] => 9735755
[patent_doc_number] => 20140271467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'PROBES AND METHODS OF IMAGING NON-HODGKINS LYMPHOMA'
[patent_app_type] => utility
[patent_app_number] => 14/204039
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14848
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14204039
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/204039 | Probes and methods of imaging non-Hodgkins lymphoma | Mar 10, 2014 | Issued |
Array
(
[id] => 10654802
[patent_doc_number] => 20160000946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'RADIOLABELED ANTI-GLYPICAN-3 IMMUNOCONJUGATES FOR IMMUNO-PET IMAGING OF HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 14/773162
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13476
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773162
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773162 | RADIOLABELED ANTI-GLYPICAN-3 IMMUNOCONJUGATES FOR IMMUNO-PET IMAGING OF HEPATOCELLULAR CARCINOMA | Mar 6, 2014 | Abandoned |
Array
(
[id] => 10863411
[patent_doc_number] => 08889100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'
[patent_app_type] => utility
[patent_app_number] => 14/199625
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 31
[patent_no_of_words] => 59849
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199625
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/199625 | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules | Mar 5, 2014 | Issued |
Array
(
[id] => 9735778
[patent_doc_number] => 20140271490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'BACTERIA-TARGETED MAGNETIC RESONANCE CONTRAST AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/198853
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8614
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198853
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/198853 | Bacteria-targeted magnetic resonance contrast agents | Mar 5, 2014 | Issued |